Why the study?
Does risk factor modification prevent atherosclerotic complications and improve survival in patients with cardiovascular, cerebrovascular, and peripheral vascular disease?
Does risk factor modification prevent atherosclerotic complications and improve survival in patients with cardiovascular, cerebrovascular, and peripheral vascular disease?
This review emphasizes the importance of comprehensive risk factor modification across multiple vascular beds to improve outcomes in atherosclerotic disease.
Answers are grounded in this paper and cite their sources.
No clinical data available on risk factor modification; leaves open its impact on atherosclerotic outcomes across vascular beds.
Based on current knowledge, it appears that atherosclerosis is a multifactorial disease. There are differences in the effects of atherosclerotic risk factors between the various vascular beds. More than one risk factor is found in the majority of the patients and, often there is atherosclerotic involvement of several vascular territories. In order to prevent or retard atherosclerotic complications and improve patient survival, it is prudent that all the major modifiable risk factors should be corrected in patients with cardiovascular, cerebrovascular, and peripheral vascular disease.
No takes yet. Share an insight, caveat, or question.
Mohan et al. (2005) conducted a review in atherosclerotic arterial disease. risk factor modification was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: